体质指数与胸部男性化手术术后并发症的关联:更新分析
单中心、单术者回顾性队列纳入2022年11月至2025年1月取消BMI界值后接受双切口乳房切除加游离乳头移植的92例患者,平均BMI 32.2(7.3)kg/m²。手术并发症发生率为20.7%,以浅表手术部位感染为主(12.0%),仅1例(1.1%)因术后贫血需输血。BMI每增加1 kg/m²,感染风险升高10%(aOR 1.10;95%CI 1.01-1.20;P=0.029),不良美学结局风险升高12%(aOR 1.12;95%CI 1.04-1.20;P=0.002)。
要点
- BMI升高与手术部位感染及瘢痕增宽/增生、站立锥畸形等美学不良结局相关。
- 严重并发症罕见,不应将BMI作为绝对手术禁忌证。
- 建议采用风险分层方式指导术前规划与患者咨询。
核心结论
- 较高BMI与胸部男性化手术后手术部位感染和不良美学结局风险升高相关,但严重并发症仍罕见。
- 术者不应将BMI作为绝对禁忌证,应采用风险分层方法指导诊疗。
研究设计与样本
- 单中心、单术者回顾性队列研究,纳入2022年11月至2025年1月取消BMI界值后接受双切口乳房切除加游离乳头移植的胸部男性化手术患者92例。
- BMI按连续变量及WHO指南分类变量分析,并校正混杂因素。
主要发现
- 92例患者平均(SD)BMI为32.2(7.3)kg/m²。
- 手术并发症发生率为20.7%(n=19),其中大多数为浅表手术部位感染(12.0%,n=11)。
- 除1例(1.1%)因术后贫血需输血外,未发生其他严重并发症。
- BMI每增加1 kg/m²,感染风险升高10%(aOR 1.10;95%CI 1.01-1.20;P=0.029)。
- 不良美学结局发生率为32.6%(n=30),BMI每增加1 kg/m²,瘢痕增宽/增生与站立锥畸形风险升高12%(aOR 1.12;95%CI 1.04-1.20;P=0.002)。
临床怎么用
- 术前咨询可依据BMI分层告知感染与美学不良结局风险,而非以BMI界值直接拒绝手术。
- 对较高BMI患者加强手术部位感染预防与瘢痕管理随访。
局限性
- 为单中心、单术者回顾性研究,样本量92例,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Institutional preoperative body mass index (BMI) cutoffs for chest masculinization surgery (CMS) lack standardization and are based on limited data. After our group's NSQIP study found no severe morbidity or mortality in patients of higher BMI, we eliminated BMI cutoffs and collected additional measurements such as aesthetic and wound healing outcomes. This is a single-institution follow-up study to evaluate CMS outcomes in higher BMI patients to better guide preoperative planning and patient counseling. METHODS: We conducted a retrospective, single-surgeon cohort study of patients who underwent CMS with double-incision mastectomy and free nipple grafting between November 2022 and January 2025, after elimination of BMI cutoffs. Primary outcomes included postoperative surgical complications requiring intervention and adverse aesthetic outcomes. We also collected major complications (e.g., venous thromboembolism, pulmonary embolism, sepsis, acute kidney injury). We analyzed BMI as both a continuous and a categorical variable per WHO guidelines, adjusting for confounders. RESULTS: Among 92 patients, the mean (SD) BMI was 32.2 (7.3) kg/m 2 . Surgical complications occurred in 20.7% (n = 19) of patients, of which most were superficial surgical site infections (12.0%, n = 11). No major complications occurred except for one case requiring blood transfusion for postoperative anemia (1.1%). Each 1-kg/m 2 increase in BMI was associated with 10% higher odds of infection (aOR, 1.10; 95% CI, 1.01-1.20; P = 0.029). Adverse aesthetic outcomes occurred in 32.6% of patients (n = 30), with each 1-kg/m 2 BMI increase associated with 12% higher odds of scar widening/hypertrophy and standing cone deformity (aOR, 1.12; 95% CI, 1.04-1.20; P = 0.002). CONCLUSIONS: Higher BMI was associated with increased risk of surgical site infection and adverse aesthetic outcomes following CMS. Major complications remained rare. Surgeons should avoid using BMI as an absolute contraindication and adopt a risk-stratified approach to guide care.
引用
- Blackman C, Wang M, Hassan B, et al. Association of Body Mass Index With Postoperative Complications After Chest Masculinization Surgery: An Updated Analysis. Ann Plast Surg. 2025. PMID: 41081597. doi:10.1097/SAP.0000000000004493
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。